|
NEK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.3309026344125E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79970047145639E-10 |
| Normal-vs-Stage2 |
2.801200E-03 |
| Normal-vs-Stage3 |
4.009200E-04 |
| Normal-vs-Stage4 |
1.51833999999518E-05 |
| Stage1-vs-Stage2 |
7.827000E-01 |
| Stage1-vs-Stage3 |
8.475200E-01 |
| Stage1-vs-Stage4 |
7.927600E-01 |
| Stage2-vs-Stage3 |
9.265200E-01 |
| Stage2-vs-Stage4 |
6.498600E-01 |
| Stage3-vs-Stage4 |
7.024600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18489995593052E-10 |
| Normal-vs-AfricanAmerican |
7.40269999743859E-08 |
| Normal-vs-Asian |
5.849300E-04 |
| Caucasian-vs-AfricanAmerican |
8.075200E-01 |
| Caucasian-vs-Asian |
8.674200E-01 |
| AfricanAmerican-vs-Asian |
9.291800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05480077397624E-12 |
| Normal-vs-Female |
1.619950E-02 |
| Male-vs-Female |
6.022300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.37049999995964E-06 |
| Normal-vs-Extreme_Weight |
3.15802939354626E-12 |
| Normal-vs-Obese |
3.68820000000714E-05 |
| Normal-vs-Extreme_Obese |
3.533800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.389400E-01 |
| Normal_Weight-vs-Obese |
4.316000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.846000E-01 |
| Extreme_Weight-vs-Obese |
2.820100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.930000E-01 |
| Obese-vs-Extreme_Obese |
6.672200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.087870E-02 |
| Normal-vs-Age(41-60Yrs) |
2.59239999467198E-08 |
| Normal-vs-Age(61-80Yrs) |
6.33330055066494E-11 |
| Normal-vs-Age(81-100Yrs) |
9.631400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.433800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.372200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.367800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.941000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.047400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.115000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.40969474876829E-11 |
| Normal-VS-Type2 PRCC |
2.28710000049759E-07 |
| Normal-VS-KIRP CIMP |
1.878780E-01 |
| Normal-VS-Unclassified PRCC |
2.264600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.742400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.736240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.925200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.501000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.050400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.430400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.16909815162103E-11 |
| Normal-vs-N1 |
2.200800E-03 |
| Normal-vs-N2 |
3.421200E-04 |
| N0-vs-N1 |
3.543500E-02 |
| N0-vs-N2 |
9.953600E-01 |
| N1-vs-N2 |
3.672600E-01 |
|
|
